A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 148
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : VTEs
Long Form : venous thromboembolic events
No. Year Title Co-occurring Abbreviation
2022 Comparison of Anti-factor Xa Levels in Female and Male Patients with Obesity After Enoxaparin Application for Thromboprophylaxis. aFXa, BMI
2022 Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials. CPK, HZ, MACEs, OI, PsA, TEAEs
2021 Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy. CAR-T, CPAEs, ROR
2021 Cardiovascular Events, Sleep Apnoea, and Pulmonary Hypertension in Primary Sjogren's Syndrome: Data from the French Health Insurance Database. aHR, CVEs, IHDs, PH, pSS, SAS
2021 Effect of Comorbidity Burden on the Risk of Venous Thromboembolic Events After Total Knee Arthroplasty. DVT, ECI, ORs, TKA
2021 Hypercoagulable Disorders in Orthopaedics: Etiology, Considerations, and Management. HCDs
2021 Incidence and Risk Factors for Postoperative Venous Thromboembolic Events in Patients Undergoing Cervical Spine Surgery. ACDF, ICD, OR, PCF
2021 Inpatient mortality and healthcare resource utilization of nontraumatic intracerebral hemorrhage complications in the US. HCRU, ICH, UTIs
2021 Postapproval Comparative Safety Study of Tofacitinib and Biological Disease-Modifying Antirheumatic Drugs: 5-Year Results from a United States-Based Rheumatoid Arthritis Registry. AE, bDMARDs, CI, HRs, HZ, IRs, MACE, PS, RA, SIEs, US
10  2021 Venous Thromboembolism Among Patients With Inflammatory Bowel Diseases is Not Related to Increased Thrombophilia: A Case-Control Study. IBD, IBD-VTE, non-IBD-VTE
11  2021 Venous thromboembolism events in patients with advanced cancer on immune checkpoint inhibitors. ICI, OR
12  2021 Venous thrombotic events in patients treated with immune checkpoint inhibitors for non-small cell lung cancer: A retrospective multicentric cohort study. ICIs, NSCLC
13  2020 A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line Chemotherapy. CI, mGCTs, NNH, NNT
14  2020 Comparison of Novel Oral Anticoagulants and Vitamin K Antagonists in Patients With Cerebral Venous Sinus Thrombosis on Efficacy and Safety: A Systematic Review. CI, CVST, NOACs, RCT, RR, VKAs
15  2020 Effect of tofacitinib on cardiovascular events and all-cause mortality in patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis of randomized controlled trials. CVEs, IMIDs, MACEs
16  2020 High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08. CRT, IR
17  2020 Inherited Risk Factors of Thromboembolic Events in Patients with Primary Nephrotic Syndrome. NS
18  2020 Intravenous Tranexamic Acid Safely and Effectively Reduces Transfusion Rates in Revision Total Knee Arthroplasties. TKA, TXA
19  2020 NSQIP Impacts Patient Experience. SARs, VTEP
20  2020 Relationship of Platelet Glycoprotein IIb/IIIa and CD62P With Hypercoagulable State After Oncologic Surgery. ---
21  2020 Risk for Venous Thromboembolic Events in Patients With Advanced Urinary Tract Cancer Treated With First-Line Chemotherapy. aUTC, CI, RAMs
22  2020 Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme. CPK, MACEs, RA, TEAEs
23  2020 Trial protocol: preoperative administration of tranexamic acid in sleeve gastrectomy (PATAS) to reduce haemorrhage rates. A randomised controlled trial. LSG, MEC-U, PATAS, TXA
24  2020 Unjustified Administration in Liberal Use of Tranexamic Acid in Trauma Resuscitation. TXA
25  2020 Venous thromboembolic events in patients with brain metastases: the PICOS score. AUC, CI, PICOS
26  2019 ABO blood group influences risk of venous thromboembolism and myocardial infarction. AF, ATEs, MI, PE
27  2019 Cardiovascular complications of metastatic colorectal cancer treatment. AE, CRC, CV, HF
28  2019 Evaluation of Venous Thromboembolic Event Prophylaxis in Hospitalized Cancer Patients: A Single-Centered Retrospective Study. ---
29  2019 General practitioner use of D-dimer in suspected venous thromboembolism: historical cohort study in one geographical region in the Netherlands. GP
30  2019 Impact of Janus kinase inhibitors on risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials. CVEs, MACEs, RA, RCTs
31  2019 Intra-articular 1g tranexamic acid administration during total knee arthroplasty is safe and effective for the reduction of blood loss and blood transfusion. CT, DVT, PE, TKA, TXA
32  2019 Intravenous tranexamic acid safely and effectively reduces transfusion rates in revision total hip arthroplasty. ASA, CI, RR, THAs, TXA
33  2019 Klippel-Trenaunay Syndrome. ---
34  2019 Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy. MN
35  2019 Risk Factors for Postoperative Venous Thromboembolic Events in Patients Undergoing Lumbar Spine Surgery. ORs
36  2019 Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis: A Randomized Clinical Trial. CVT
37  2019 Symptomatic Deep Vein Thrombosis Following Elective Knee Arthroscopy Over the Age of 40. AKS, DM, DVT
38  2019 The role of prophylactic use of low molecular weight heparin or aspirin in thromboembolic events in primary membranous nephropathy. ATEs, LMWH, PMN
39  2019 Therapeutic strategies of thromboembolic events in patients with inflammatory bowel diseases: Two case reports. CD, CT, DSA, DVT, IBD, PE, TEEs, UC
40  2019 Timing and Risk Factors for Venous Thromboembolism After Rotator Cuff Repair in the 30-Day Perioperative Period. CI, OR, RCRs
41  2019 Tofacitinib for the treatment of rheumatoid arthritis: an update. MTX
42  2019 Tranexamic Acid Use in Open Reduction and Internal Fixation of Fractures of the Pelvis, Acetabulum, and Proximal Femur: A Randomized Controlled Trial. TBL, TXA
43  2019 Venous thromboembolic events in patients undergoing craniotomy for tumor resection: incidence, predictors, and review of literature. ---
44  2018 A Cohort Study of Incidences and Risk Factors for Thromboembolic Events in Patients with Idiopathic Membranous Nephropathy. ATEs, IMN, IS, NS
45  2018 Factors associated with venous thromboembolic events following ICU admission in patients undergoing spinal surgery: an analysis of 1269 consecutive patients. ICU
46  2018 Incidence and Risk Factors of Symptomatic Venous Thromboembolism Following Foot and Ankle Surgery. aOR
47  2018 Incidence of symptomatic venous thromboembolism in 2372 knee and hip replacement patients after discharge: data from a thromboprophylaxis registry in Montreal, Canada. LMWH
48  2018 Novel venous thromboembolic disease (VTED) prophylaxis for total knee arthroplasty-aspirin and fish oil. CIs, DVT, OR, ORs, PE, TKA, VTED
49  2018 Preinjury statin use and thromboembolic events in trauma: a 10-year retrospective evaluation. SR
50  2018 Treatment of Lower Extremity Superficial Thrombophlebitis. LMWH, NSAIDs, ST
51  2018 Venous Thromboembolic Events in Idiopathic Inflammatory Myopathy: Occurrence and Relation to Disease Onset. HR, IIMs
52  2018 Venous thromboembolic events in patients with lung cancer treated with cisplatin-based versus carboplatin/nedaplatin-based chemotherapy. ---
53  2018 Venous Thromboembolism Prophylaxis in Shoulder Surgery. ---
54  2018 [Tamoxifen induced thromboembolic events in breast cancer. Some possible mechanisms]. ---
55  2017 High prevalence of incidental and symptomatic venous thromboembolic events in patients with advanced pancreatic cancer under palliative chemotherapy: A retrospective cohort study. ---
56  2017 Risk of venous and arterial thromboembolic events associated with VEGFR-TKIs: a meta-analysis. ATEs, CIs, RR
57  2017 Rivaroxaban: An Affordable and Effective Alternative in Cancer-Related Thrombosis? LMWH
58  2017 The timing of venous thromboembolic events after spine surgery: a single-center experience with 6869 consecutive patients. DVT
59  2016 A single-center prospective study on the safety of plasma exchange procedures using a double-viral-inactivated and prion-reduced solvent/detergent fresh-frozen plasma as the replacement fluid in the treatment of thrombotic microangiopathy. HIV, PEX, TMAs
60  2016 Aspirin Can Be Used as Prophylaxis for Prevention of Venous Thromboembolism After Revision Hip and Knee Arthroplasty. TJA
61  2016 Can Thrombelastography Predict Venous Thromboembolic Events in Patients With Severe Extremity Trauma? ma
62  2016 Deep Vein Thrombosis: An Independent Poor Prognosis Factor of Advanced Pancreatic Adenocarcinoma. CI, HR, PA
63  2016 Estimating Risk of Venous-Thromboembolic Events in Hospitalized Medical Patients: Comparison between 2008 and 2012 Guidelines. ACCP, RAM
64  2016 H1N1-Induced Venous Thromboembolic Events? Results of a Single-Institution Case Series. DVT, PE, pH1N1
65  2016 Low-Molecular-Weight Heparin Prophylaxis Dosing: Is Weight an Issue? LMWHs
66  2016 OC-01 - Clinical history of cancer patients with isolated distal deep vein thrombosis: a multicenter cohort study. DVT, IDDVT, PE
67  2016 Peri-articular tranexamic acid injection in total knee arthroplasty: a randomized controlled trial. Hb, IV TXA, TKA
68  2016 Prevalence of Symptomatic and Asymptomatic Thrombosis in Pediatric Oncology Patients With Tunneled Central Venous Catheters. CABSIs, CI, CVCs, US
69  2016 Safety of Pregnancy After Cerebral Venous Thrombosis: A Systematic Review. CVT
70  2016 Thromboembolic and major bleeding events in relation to perioperative bridging of vitamin K antagonists in 649 fast-track total hip and knee arthroplasties. ATEs, MBs, VKA
71  2016 Thromboembolic Events After Arthroscopic Knee Surgery: Increased Risk at High Elevation. PE
72  2016 Thromboprophylaxis in Ambulatory Trauma Patients With Foot and Ankle Fractures: Prospective Study Using a Risk Scoring System. LMWH
73  2015 A phase I dose-escalation study of lenalidomide in combination with gemcitabine in patients with advanced pancreatic cancer. AEs, DLT, LMWH, MTD
74  2015 Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial. APC, HR
75  2015 How to use D-dimer in acute cardiovascular care. ---
76  2015 Incidence and Risk Factor Analysis of Symptomatic Venous Thromboembolism After Knee Arthroscopy. CI, DVTs, OR, PEs
77  2015 Post-transplant venous thromboembolic events and their effect on graft survival. ---
78  2015 Risk Factors for Thromboembolic Events After Surgery for Ankle Fractures. ACS-NSQIP, BMI, CI, OR, ORIF
79  2015 Severe hepatic dysfunction is associated with venous thromboembolic events in phase 1 clinical trials. HDCTs, NCI, P1CTs
80  2015 The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients. LMWHs
81  2015 TXA in combat casualty care--does it adversely affect extremity reconstruction and flap thrombosis rates? TXA
82  2015 Unmet Needs in Anticoagulant Therapy: Potential Role of Rivaroxaban. AF, DVT, NOACs, PE, SSE
83  2014 Burden and timing of venothrombolic events in patients younger than 65 years undergoing radical cystectomy for bladder cancer. RC
84  2014 Cardiovascular events and bleeding risk associated with intravitreal antivascular endothelial growth factor monoclonal antibodies: systematic review and meta-analysis. AMD, anti-VEGF, DME, mAb, ORs, RVOs
85  2014 Cardiovascular safety of conjugated estrogens plus bazedoxifene: meta-analysis of the SMART trials. CE/BZA, CHD
86  2014 Increased risk of venous thromboembolic events with corticosteroid vs biologic therapy for inflammatory bowel disease. ---
87  2014 Lack of Clinical Benefit of Thromboprophylaxis in Patients Hospitalized in a Medical Unit Over a 10-year Span. ---
88  2014 Prevention of venous thromboembolic events with low-molecular-weight heparin in the non-major orthopaedic setting: meta-analysis of randomized controlled trials. CI, LMWH, RR
89  2014 Searching for indirect evidence and extending the network of studies for network meta-analysis: case study in venous thromboembolic events prevention following elective total knee replacement surgery. NICE, NMAs
90  2014 Selective estrogen receptor alpha agonist GTx-758 decreases testosterone with reduced side effects of androgen deprivation therapy in men with advanced prostate cancer. IGF, PSA
91  2014 Surgical operative time increases the risk of deep venous thrombosis and pulmonary embolism in robotic prostatectomy. RARP
92  2014 Thromboembolic events in women exposed to hormonal contraception or cyproterone acetate in 2012: a cross-sectional observational study in 30 French public hospitals. ATEs
93  2014 Venous Thromboembolic Events After Spinal Fusion: Which Patients Are at High Risk? NIS
94  2013 Impact of chronic kidney disease on the risk of clinical outcomes in patients with cancer-associated venous thromboembolism during anticoagulant treatment. CKD, LMWH, PY, VKA
95  2013 Lenalidomide in combination with gemcitabine as first-line treatment for patients with metastatic carcinoma of the pancreas: a Sarah Cannon Research Institute phase II trial. ---
96  2013 Screening for coagulopathy and identification of children with acute lymphoblastic leukemia at a higher risk of symptomatic venous thrombosis: an AIEOP experience. ALL
97  2013 Symptomatic venous thrombo-embolism in low-energy isolated fractures in hospitalised patients. BMI, DVT, PE
98  2013 Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters. ASCO, ASH, AT, CCTs, CENTRAL, CI, CVCs, FFP, HIT, HITT, ISRCTN, ISTH, LMWH, NIH, PTS, RCTs, RR, SIOP
99  2013 The differential effects of intermediate complications with postoperative mortality. SSIs, UTIs
100  2013 Venous thromboembolic events in minimally invasive gynecologic surgery. ---